Patents by Inventor Gregory M. Glenn

Gregory M. Glenn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230212365
    Abstract: The invention provides moisture-resistant foam compositions comprising at least one fiber component; at least one foaming agent; at least one wax binder; and optionally at least one dispersant, where the at least one fiber component, the at least one foaming agent, the at least one wax binder, and when present the at least one dispersant are uniformly dispersed throughout a matrix, wherein the matrix is a foam.
    Type: Application
    Filed: December 29, 2022
    Publication date: July 6, 2023
    Inventors: GREGORY M. GLENN, RANDAL SHOGREN, XING JIN
  • Publication number: 20230212366
    Abstract: Provided herein is a molded cellulose foam having a smooth, dense surface fiber layer and a low density, open-cell structure interior, a process for compression-molding fiber foam into such molded cellulose foam, articles prepared with such foam, and articles prepared by such process.
    Type: Application
    Filed: July 28, 2022
    Publication date: July 6, 2023
    Inventor: Gregory M. Glenn
  • Publication number: 20230173052
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Application
    Filed: September 9, 2022
    Publication date: June 8, 2023
    Applicants: VALNEVA AUSTRIA GMBH, VALNEVA USA, INC.
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Patent number: 11478540
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: October 25, 2022
    Assignees: Valneva Austria GmbH, Valneva USA, Inc.
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Patent number: 11402252
    Abstract: A server system for remote monitoring includes a wireless communication interface, a processor, and a storage device. The wireless communication interface receives at least one data packet over wireless communications from a remote monitoring system. The processor processes the data packet including sensor information from a sensor coupled to the remote monitoring system. The storage device stores the sensor information.
    Type: Grant
    Filed: November 12, 2019
    Date of Patent: August 2, 2022
    Assignee: Arthroscopic Surgery Associates Corporation
    Inventors: Gregory M. Glenn, Damon Silva, Timothy Henry
  • Patent number: 11357844
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: June 14, 2022
    Assignees: Valneva Austria GmbH, Valneva USA, Inc.
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Patent number: 11339275
    Abstract: Compositions comprising a fiber component, optionally a dispersing agent operable to disperse the fiber component to create a fiber matrix, a starch component distributed essentially throughout the fiber matrix, and a filler component are disclosed. Methods of forming articles such as containers and packages from such compositions are also disclosed.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: May 24, 2022
    Assignees: The United States of America, as represented by the Secretary of Agriculture, World Centric
    Inventors: Gregory M. Glenn, Xing Jin
  • Publication number: 20220049428
    Abstract: The invention relates to uncoated, fiber/starch composite materials manufactured without the use of fluorochemicals or additional binders that offer superior oil and grease resistance properties. Addition of an internal sizing agent in the preparation of the fiber/starch composite materials results in superior hot water and cold water resistance properties. The fiber/starch composite materials may be used for the manufacture of food service containers. The invention also relates to methods of preparation of the fiber/starch composite materials.
    Type: Application
    Filed: August 13, 2021
    Publication date: February 17, 2022
    Inventors: GREGORY M. GLENN, XING JIN, RANDAL L. SHOGREN
  • Publication number: 20210393761
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Application
    Filed: August 19, 2021
    Publication date: December 23, 2021
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Publication number: 20210121554
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Application
    Filed: October 2, 2020
    Publication date: April 29, 2021
    Applicants: Valneva Austria GmbH, Valneva USA, Inc.
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Publication number: 20210040693
    Abstract: Disclosed are methods that facilitate formation of a continuous layer of aqueous coating on the surface of paper-based products via appropriate hydrophobicity on the to-be-coated surface. The methods are applied to provide useful characteristics or functions to paper products, for example, good oil resistance. The methods do not involve the use of polyfluoroalkyl substances (PFAS).
    Type: Application
    Filed: August 7, 2020
    Publication date: February 11, 2021
    Inventors: Gregory M. Glenn, Artur P. Klamczynski, Xing Jin
  • Patent number: 10821166
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: November 3, 2020
    Assignees: Valneva Austria GmbH, Valneva USA, Inc.
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Publication number: 20200308359
    Abstract: A composition comprising a fiber component, at least one surfactant/foaming agent, at least one dispersant, and optionally at least one binder, wherein the fiber component forms a viscous mixture that is converted to a foam product upon the addition of the surfactant/foaming agent once the viscous mixture reaches a predetermined dryness, wherein the foam product is resistant to shrinkage during drying and remains rigid.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 1, 2020
    Inventors: Gregory M. Glenn, Xing Jin, Gaunt Murdock
  • Publication number: 20200124459
    Abstract: A server system for remote monitoring includes a wireless communication interface, a processor, and a storage device. The wireless communication interface receives at least one data packet over wireless communications from a remote monitoring system. The processor processes the data packet including sensor information from a sensor coupled to the remote monitoring system. The storage device stores the sensor information.
    Type: Application
    Filed: November 12, 2019
    Publication date: April 23, 2020
    Inventors: Gregory M. Glenn, Damon Silva, Timothy Henry
  • Patent number: 10473504
    Abstract: A server system for remote monitoring includes a wireless communication interface, a processor, and a storage device. The wireless communication interface receives at least one data packet over wireless communications from a remote monitoring system. The processor processes the data packet including sensor information from a sensor coupled to the remote monitoring system. The storage device stores the sensor information.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: November 12, 2019
    Assignee: ARTHROSCOPIC SURGERY ASSOCIATES CORPORATION
    Inventors: Gregory M. Glenn, Damon Silva, Timothy Henry
  • Patent number: 10473505
    Abstract: A server system for remote monitoring includes a wireless communication interface, a processor, and a storage device. The wireless communication interface receives at least one data packet over wireless communications from a remote monitoring system. The processor processes the data packet including sensor information from a sensor coupled to the remote monitoring system. The storage device stores the sensor information.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: November 12, 2019
    Assignee: ARTHROSCOPIC SURGERY ASSOCIATES CORPORATION
    Inventors: Gregory M. Glenn, Damon Silva, Timothy Henry
  • Publication number: 20190290747
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Application
    Filed: March 7, 2019
    Publication date: September 26, 2019
    Applicant: Valneva Austria GmbH
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Patent number: 10378945
    Abstract: A server system for remote monitoring includes a wireless communication interface, a processor, and a storage device. The wireless communication interface receives at least one data packet over wireless communications from a remote monitoring system. The processor processes the data packet including sensor information from a sensor coupled to the remote monitoring system. The storage device stores the sensor information.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: August 13, 2019
    Assignee: Arthroscopic Surgery Associates Corporation
    Inventors: Gregory M. Glenn, Damon Silva, Timothy Henry
  • Patent number: 10357557
    Abstract: This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: July 23, 2019
    Assignees: Valneva Austria GmbH, Valneva USA, Inc.
    Inventors: Larry R. Ellingsworth, David Flyer, Jing-Hui Tian, Steven R. Fuhrmann, Stefanie Kluepfel-Stahl, Gregory M. Glenn, Kerstin Westritschnig
  • Publication number: 20190092931
    Abstract: Compositions comprising a fiber component, optionally a dispersing agent operable to disperse the fiber component to create a fiber matrix, a starch component distributed essentially throughout the fiber matrix, and a filler component are disclosed. Methods of forming articles such as containers and packages from such compositions are also disclosed.
    Type: Application
    Filed: September 27, 2018
    Publication date: March 28, 2019
    Inventors: Gregory M. Glenn, Xing Jin